7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/23/2013

Company Name Symbol %Change
WESTELL TECH WSTL
6.67%
STEIN MART I SMRT
5.38%
ALLIANCE FIB AFOP
5.21%
DAWSON GEOPH DWSN
4.33%
MARRIOTT VAC VAC
3.27%

Amdocs Stays Neutral

by Zacks Equity Research

March 13, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Amdocs Ltd. ( DOX - Analyst Report ) posted weak financial results for the first quarter of fiscal 2012, missing the Zacks Consensus Estimates. However, management provided a strong financial outlook for the rest of 2012. Amdocs offers a portfolio of several industry-leading technology integration products for managed services and large transformational project. Despite facing a volatile global macro economy, the company is successfully executing its operations across geographies. Amdocs benefited from the long-term trend toward information technology outsourcing. We believe the long-term fundamentals of Amdocs remain intriguing primarily due to the transition of telecommunications industry to converged IP solutions.

Beside telecom, Amdocs commands a strong foothold within the cable TV industry. In a significant contract win, Amdocs recently extended its existing business agreement with Comcast Corp. ( CMCSA - Analyst Report ) , the largest cable MSO in the U.S. The extension period is for multi year period, during which Amdocs will supply various products from its CES platform. The company also won three strategic contracts in the Caribbean and Latin American regions. In December 2011, Amdocs won a major contract in Europe. Virgin Media Inc. ( VMED - Analyst Report ) , a leading integrated pay-TV and telecom operator in the U.K., selected the company to revamp its network inventory management system.

A major problem for Amdocs is that its ongoing business fluctuations with AT&T Inc. ( T - Analyst Report ) . AT&T has either terminated or postponed several transformational deals with Amdocs, after its failed attempt to acquire T-Mobile USA. AT&T is the biggest customer of Amdocs, accounting for about 29%-30% of the company’s total revenue. Had the proposed merger materialized, the services integration of the two platforms may generate incremental $75 million - $100 million revenue per annum for Amdocs. The company may face severe top-line volatility if it fails to restore its previous revenue run rate with AT&T.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.